Cargando…
Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure
Myosin modulators are a novel class of pharmaceutical agents that are being developed to treat patients with a range of cardiomyopathies. The therapeutic goal of these drugs is to target cardiac myosins directly to modulate contractility and cardiac power output to alleviate symptoms that lead to he...
Autores principales: | Day, Sharlene M., Tardiff, Jil C., Ostap, E. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884898/ https://www.ncbi.nlm.nih.gov/pubmed/35229734 http://dx.doi.org/10.1172/JCI148557 |
Ejemplares similares
-
Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine
por: Greenberg, Michael J., et al.
Publicado: (2021) -
Sex‐Related Differences in Genetic Cardiomyopathies
por: Argirò, Alessia, et al.
Publicado: (2022) -
Myosin Modulators: The New Era of Medical Therapy for Systolic Heart Failure and Hypertrophic Cardiomyopathy
por: Lekaditi, Dimitra, et al.
Publicado: (2021) -
Getting inside the engine - myosin modulation in hypertrophic cardiomyopathy and systolic heart failure
por: Daniels, Matthew J, et al.
Publicado: (2021) -
Biophysics of the failing heart: physics and biology of heart muscle
por: Solaro, R, et al.
Publicado: (2013)